Use of intravaginal microbicides to prevent acquisition of Trichomonas vaginalis infection in Lactobacillus-pretreated, estrogenized young mice

American Journal of Tropical Medicine and Hygiene

Volumn 63, Issue 5-6, 2000, Pages 284-289

  Lushbaugh, W B ^a   Blossom, A C ^a   Shah, P H ^a   Banga, A K ^a   Jaynes, J M ^a   Cleary, J D ^a   Finley, R W ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CONJUGATED ESTROGEN; D2A21; ESTROGEN; METRONIDAZOLE; PLACEBO; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; ESTROGEN BLOOD LEVEL; FEMALE; INFECTION PREVENTION; INFECTION RISK; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS GASSERI; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS VAGINALIS; MOUSE; NONHUMAN; TRICHOMONAS VAGINALIS; TRICHOMONIASIS;

ANIMALIA; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS GASSERI; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS VAGINALIS; PROTOZOA; TRICHOMONAS VAGINALIS;

EID: 0034438236     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2000.63.284     Document Type: Article

References (47)

1. An overview of selected curable sexually transmitted diseases
2. Sexually transmitted diseases among sex workers in KwaZulu-Natal, South Africa
3. Etiology of sexually transmitted diseases among street-based female sex workers in Dhaka, Bangladesh
4. Community based study of sexually transmitted diseases in rural women in the highlands of Papua New Guinea: Prevalence and risk factors
5. The tampon test for trichomoniasis: A comparison between conventional methods and a polymerase chain reaction for Trichomonas vaginalis in women
6. A double-blind placebo-controlled trial of single-dose intravaginal versus single-dose oral metronidazole in the treatment of trichomonal vaginitis
7. Rates of and risk factors for trichomoniasis among pregnant inmates in New York City
8. Trichomonas vaginalis: Reevaluation of its clinical presentation and laboratory diagnosis
9. Sexual intercourse during pregnancy and preterm delivery: Effects of vaginal microorganisms
10. Clinical and microbiological correlates of vaginal trichomoniasis during pregnancy
11. Trichomonas vaginalis associated with low birth weight and preterm delivery
12. Non-ulcerative sexually transmitted diseases (STD) as risk factors for HIV-1 transmission in women: Results from a cohort study
13. Barrier contraceptives and sexually transmitted diseases in women: A comparison of female-dependent methods and condoms
14. Defensins. Natural peptide antibiotics of human neutrophils
15. Channel-forming properties of cecropins and related model compounds incorporated into planar lipid membranes
16. In vitro activities of designed antimicrobial peptides against multidrug-resistant cystic fibrosis pathogens
17. Intravaginal growth of Trichomonas vaginalis in mice
18. Mouse intravaginal infection with Trichomonas vaginalis and role of Lactobacillus acidophilus in sustaining infection
19. The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species
20. Pathogenicity of fresh isolates of Trichomonas vaginalis: The mouse assay vs. clinical and pathologic findings
21. Three aspecific ATPases in Trichomonas vaginalis
22. Cytotoxicity of hamycin for Trichomonas vaginalis, HeLa and BHK-21
23. Interactions between Trichomonas vaginalis and vaginal flora in a mouse model
24. Composition of the Lactobacillus acidophilus complex isolated from vaginal flora
25. Identification and plasmid profiles of Lactobacillus species from the vaginas of 100 healthy women
26. On injury of the epithelium of the vagina caused by Trichomonas vaginalis in experimental animals
27. Features of intravaginal Trichomonas vaginalis infection in the mouse and the effect of oestrogen treatment and immunodepression
28. Die Chemotherapie der vaginalen trichomoniasis und candidosis der maus
29. Intravaginal infection of the rat with Trichomonas vaginalis and Candida albicans. An experimental model for chemotherapy
30. The efficacy of established, systemically active trichomonacidal agents in the rat infection model of Trichomonas vaginalis
31. Infection of female squirrel monkeys (Saimiri sciureus) with Trichomonas vaginalis as a model of trichomoniasis in women
32. Inducible immunity to Trichomonas vaginalis in a mouse model of vaginal infection
33. Comparative pathogenicity of Trichomonas vaginalis and Trichomonas gallinae to mice. II. Histopathology of subcutaneous lesions
34. A pilot study of metronidazole vaginal gel versus oral metronidazole for the treatment of Trichomonas vaginalis vaginitis
35. Metronidazole. A therapeutic review and update
36. Cure of metronidazole- and tinidazole-resistant trichomoniasis with use of high-dose oral and intravaginal tinidazole
37. Efficacy of intravaginal 0.75 % metronidazole gel for the treatment of bacterial vaginosis
38. In vitro cytocidal effect of novel lytic peptides on Plasmodium falciparum and Trypanosoma cruzi
39. In vitro activities of lytic peptides against the sporozoites of Cryptosporidium parvum
40. Microbicides, meta-analysis, and the N-9 question. Where's the research?
41. Use of nonoxynol-9 and changes in vaginal lactobacilli
42. Family planning, sexually transmitted diseases and contraceptive choice: A literature update - Part I
43. Is metronidazole teratogenic? A meta-analysis
44. Effect of chlorhexidine on genital microflora, Neisseria gonorrhoeae, and Trichomonas vaginalis in vitro
45. Design of a "microbicide" for prevention of sexually transmitted diseases using "inactive" pharmaceutical excipients